From the results of the ORIGIN trial [7] and the meta‐analysis on cardiovascular incidence in T2DM patients [28, 29], insulin use showed no significant association with increasing stroke incidence or cardiovascular death in patients with T2DM. This evidence concerns the gene INS and stroke disorder.